Profund Advisors LLC acquired a new position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 57,365 shares of the biotechnology company’s stock, valued at approximately $881,000. Other hedge funds and other institutional investors have also […]